| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |